AI assistant
IMPEDIMED LIMITED — Capital/Financing Update 2009
Jun 1, 2009
65135_rns_2009-06-01_0eae11d4-265a-4b60-9f7d-91d560d0a92a.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [84 x 94] intentionally omitted <==
==> picture [57 x 10] intentionally omitted <==
----- Start of picture text ----- ASX : IPD----- End of picture text -----
2[nd] June 2009
ImpediMed Limited (the Company)
ACN 65 089 705 144
Notice under section 708A(5)(e) of the Corporations Act
Further to the announcement on 28[th] May 2009 of a placement and entitlements offer, today the placement was settled and the Company has issued 7,812,500 fully paid, ordinary shares at a price of $0.64 under an underwritten placement through Wilson HTM Corporate Finance Limited (the Placement Shares).
The Company relies on case 1 in section 708A(5) of the Corporations Act 2001 (Cth) ( the Act ) in respect of the issue of the Placement Shares.
The Company gives notice under paragraph 5(e) of section 708A of the Act that:
-
1 The Company issued the Placement Shares without disclosure to the placement share investors under Part 6D.2 of the Act;
-
2 As at the date of this notice the Company has complied with:
-
(a) the financial and audit provisions of Chapter 2M of the Act insofar as they apply to the Company; and
-
(b) its continuous disclosure requirements under section 674 of the Act.
-
-
3 As at the date of this notice there is no excluded information (as defined in section 708A(7) of the Act), which is required to be disclosed by the Company.
2[nd] June 2009
ImpediMed Limited
==> picture [107 x 44] intentionally omitted <==
Phillip Stephen Auckland Chief Financial Officer & Company Secretary